Zhang et al. [55] conducted a study on rats with experimental periodontitis and found that Biochanin A treatment significantly reduced alveolar bone resorption and levels of inflammatory markers, such as IL-1β, TNF-α, and ROS. Here, IL1B is linked to periodontitis.